Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 29176 AL 29190

Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid-positive early Alzheimer's disease

Devanarayan V, Charil A, Horie K, Doherty T, Llano DA, Andreozzi E, Sachdev P, Ye Y, Murali LK, Zhou J, Reyderman L, Hampel H, Kramer LD, Dhadda S, Irizarry MC; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Alzheimers Dement. 2025 Feb;21(2):e14411. doi: 10.1002/alz.14411. Epub 2024 Nov 22.

The Role of Blood-Based Biomarkers in Transforming Alzheimer's Disease Research and Clinical Management: A Review

Pacoova Dal Maschio V, Roveta F, Bonino L, Boschi S, Rainero I, Rubino E.

Int J Mol Sci. 2025 Sep 3;26(17):8564. doi: 10.3390/ijms26178564.

Differences in Alzheimer's disease blood biomarker stability: Implications for the use of tau/amyloid ratios

Figdore DJ, Schuder BJ, Ashrafzadeh-Kian S, Gronquist T, Bornhorst JA, Algeciras-Schimnich A.

Alzheimers Dement. 2025 Apr;21(4):e70173. doi: 10.1002/alz.70173.

Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort

Bali D, Salvadó G, Beach TG, Serrano GE, Atri A, Reiman EM, Jeromin A, Hansson O, Janelidze S.

Acta Neuropathol Commun. 2025 Jun 30;13(1):144. doi: 10.1186/s40478-025-02064-2.

Transthyretin as a therapeutic target: the future of disease-modifying therapies for Alzheimer's disease

Shaw S, Porel P, Aran KR.

Mol Biol Rep. 2025 Apr 8;52(1):370. doi: 10.1007/s11033-025-10485-4.

Beyond binary classification: Comparing three region-based multi-phase Aβ staging systems

Cui L, Zhang Z, Huang CC, Yuan CY, Tu YY, Wang M, Guan YH, Li YH, Xie F, Guo QH.

Alzheimers Dement. 2025 May;21(5):e70253. doi: 10.1002/alz.70253.

Atypical Alzheimer's dementia: Addressing the subtypes, epidemiology, atypical presentations, diagnostic biomarkers, and treatment updates

Vora N, Patel P, Marsool MDM, Marsool ADM, Sunasra R, Ladani P, Pati S, Khoont D, Prajjwal P, Ranjan R.

Dis Mon. 2025 May;71(5):101863. doi: 10.1016/j.disamonth.2025.101863. Epub 2025 Feb 1.

Longitudinal Associations of Multimodal Core 1 Alzheimer Disease Biomarkers With Cognition in Aging and Preclinical Alzheimer Disease

López-Martos D, Suárez-Calvet M, Milà-Alomà M, Gispert JD, Salvadó G, Brugulat-Serrat A, Shekari M, Minguillon C, Zetterberg H, Blennow K, Grau-Rivera O, Sánchez-Benavides G; ALFA study.

Neurology. 2025 Nov 11;105(9):e214308. doi: 10.1212/WNL.0000000000214308. Epub 2025 Oct 17.

Identification of potential therapeutic targets for Alzheimer's disease from the proteomes of plasma and cerebrospinal fluid in a multicenter Mendelian randomization study

Wang S, Xi J, Zhang M, Wang J.

Int J Biol Macromol. 2025 Mar;294:139394. doi: 10.1016/j.ijbiomac.2024.139394. Epub 2025 Jan 3.

Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome

Huber H, Arranz J, Arslan B, Leuzy A, Kittel O, di Molfetta G, Benejam B, Videla L, Barroeta I, Soriano LDH, Maure-Blesa L, Rodríguez-Baz Í, Arriola Infante JE, Illán-Gala I, Bejanin A, Montoliu-Gaya L, Lleó A, Carmona-Iragui M, Alcolea D, Blennow K, Zetterberg H, Fortea J, Ashton NJ.

Nat Commun. 2025 Nov 10;16(1):9900. doi: 10.1038/s41467-025-65882-x.

Blood-based biomarkers for Alzheimer's disease in Down syndrome: A systematic review and meta-analysis

Zhou Y, Sheehan R, Guo L, Strydom A.

Alzheimers Dement. 2025 Apr;21(4):e70135. doi: 10.1002/alz.70135.

Lipofuscin accumulation in aging and neurodegeneration: a potential "timebomb" overlooked in Alzheimer's disease

Dougnon G, Matsui H.

Transl Neurodegener. 2025 Dec 12;14(1):67. doi: 10.1186/s40035-025-00529-x.

Advances in Diagnostic Approaches for Alzheimer's Disease: From Biomarkers to Deep Learning Technology

Asif M, Ullah H, Jamil N, Riaz M, Zain M, Pushparaj PN, Rasool M.

CNS Neurol Disord Drug Targets. 2025;24(12):872-881. doi: 10.2174/0118715273374284250519053646.

BACE1 as an early biomarker and its relevance to risk factors for Alzheimer's disease

Ohno M.

Brain Res Bull. 2025 Oct 1;230:111475. doi: 10.1016/j.brainresbull.2025.111475. Epub 2025 Jul 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias